Pain Reliever a Controlled Drug

The classification of tramadol (Ultram) as a Schedule IV drug highlights the potential for addiction and abuse.

Tramadol (Ultram), the alternative, synthetic opioid pain reliever, has seen increasing use since it was first approved by the Food and Drug Administration (FDA) in 1994. However, a decision by the Drug Enforcement Administration (DEA) to list tramadol as a Schedule IV controlled substance (Aug. 2014) may mean changes for how the drug is prescribed.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access